Efficacy of denosumab treatment for lung metastasis secondary to proximal humerus chondroblastoma

References

1. 1.↵
   1. Amary F,
   2. Cleven AHG,
   3. Konishi E

   . Chondroblastoma. [Updated 2020; 2023 Sep 1]. Available from: https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/Soft-Tissue-And-Bone-Tumours-2020
2. 2.↵
   1. Laitinen MK,
   2. Stevenson JD,
   3. Evans S,
   4. Abudu A,
   5. Sumathi V,
   6. Jeys LM, et al.

   Chondroblastoma in pelvis and extremities- a signle centre study of 177 cases. J Bone Oncol 2019; 17: 100248.

   OpenUrl
3. 3.↵
   1. Ozkoc G,
   2. Gonlusen G,
   3. Ozalay M,
   4. Kayaselcuk F,
   5. Pourbagher A,
   6. Tandogan RN

   . Giant chondroblastoma of the scapula with pulmonary metastases. Skeletal Radiol 2006; 35: 42–48.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Focaccia M,
   2. Gambarotti M,
   3. Hakim R,
   4. Paioli A,
   5. Cesari M,
   6. Spazzoli B, et al.

   Chondroblastoma’s lung metastases treated with denosumab in pediatric patient. Cancer Res Treat 2021; 53: 279–282.

   OpenUrl
5. 5.↵
   1. Baumhoer D,
   2. Harder D,
   3. Ameline B,
   4. Dawson H,
   5. Kollar A

   . Metastasizing chondroblastoma: a rare bone tumor no longer supported by the WHO classification. Skeletal Radiol 2021; 50: 255–260.

   OpenUrl
6. 6.↵
   1. Huang L,
   2. Cheng YY,
   3. Chow LT,
   4. Zheng MH,
   5. Kumta SM

   . Receptor activator of NF-kappaB ligand (RANKL) is expressed in chondroblastoma: possible involvement in osteoclastic giant cell recruitment. Mol Pathol 2003; 56: 116–120.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Won KY,
   2. Kalil RK,
   3. Kim YW,
   4. Park YK

   . RANK signalling in bone lesions with osteoclast-like giant cells. Pathology 2011; 43: 318–321.

   OpenUrlPubMed
8. 8.↵
   1. Suster DI,
   2. Kurzawa P,
   3. Neyaz A,
   4. Jarzembowski JA,
   5. Lozano-Calderon S,
   6. Raskin K, et al.

   Chondroblastoma expresses RANKL by RNA in situ hybridization and may respond to denosumab therapy. Am J Surg Pathol 2020; 44: 1581–1590.

   OpenUrl
9. 9.↵
   1. Calvert N,
   2. Wood D

   . Use of denosumab in recurrent chondroblastoma of the squamous temporal bone: a case report. Clin Case Rep 2017; 5: 411–413.

   OpenUrl
10. 10.↵
    1. Visgauss JD,
    2. Lazarides A,
    3. Dickson B,
    4. Cardona D,
    5. Sheth M,
    6. DeWitt SB, et al.

    Treatment of chondroblastoma with denosumab: a case report with a correlative analysis of effect on the RANK signaling pathway. JBJS Case Connect 2021; 11.